Partnering Biotech Innovation Across Borders
Senior-level strategic counsel to biotech and pharmaceutical companies navigating cross-border partnerships, licensing, and market entry.
We bridge the gap between innovative biotech companies and global market opportunities, combining deep industry expertise with modern analytical capabilities.
Principal involvement on every engagement. No junior staffing, no handoffs. Direct access to decision-makers with decades of pharmaceutical business development experience.
Deep networks across major pharmaceutical markets — US, Europe, Japan, and China. We navigate regulatory pathways (FDA, EMA, PMDA, NMPA) and cultural nuances that make cross-border deals succeed.
Advanced data processing and AI tools accelerate our research and analysis. Competitive intelligence, market mapping, and deal structuring delivered faster without compromising depth.
Strategic advisory focused on value creation for life sciences companies at inflection points.
Strategic planning and execution support for entering new markets. Partner identification, regulatory pathway analysis, and commercial strategy across US, Europe, Japan, and emerging markets.
End-to-end support for licensing, co-development, and strategic partnerships. From target identification to deal structuring and negotiation support.
Strategic guidance on acquisitions, divestitures, and portfolio optimization. Valuation support, due diligence coordination, and transaction structuring for life sciences assets.
Our partners are former pharmaceutical executives and entrepreneurs with exit experience, bringing 60+ years of combined expertise across business development, M&A, and commercial operations. Therapeutic focus spans oncology, cell therapy, central nervous system, and immunology. Capabilities include pre-clinical and clinical development strategy, HEOR, real-world evidence, financing, and NewCo design—with established networks across the US, Europe, Japan, and China.
Alignment of interests, depth of engagement, and speed of execution.
Partners directly lead every project. No delegation to junior staff. Your project receives the attention of experienced professionals who have done the deals themselves.
Modern AI and data tools accelerate our analysis without sacrificing rigor. Comprehensive market intelligence delivered in days, not weeks.
As a boutique firm, we deliberately limit our active engagements. This ensures deep attention to your project and alignment of our success with yours.